501 related articles for article (PubMed ID: 29621993)
1. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
[TBL] [Abstract][Full Text] [Related]
2. Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.
Johnson EO; Chen LS; Breslau N; Hatsukami D; Robbins T; Saccone NL; Grucza RA; Bierut LJ
Addiction; 2010 Nov; 105(11):2014-22. PubMed ID: 20840187
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
Pintarelli G; Galvan A; Pozzi P; Noci S; Pasetti G; Sala F; Pastorino U; Boffi R; Colombo F
Sci Rep; 2017 Dec; 7(1):16730. PubMed ID: 29196725
[TBL] [Abstract][Full Text] [Related]
4. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
[TBL] [Abstract][Full Text] [Related]
5. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
[TBL] [Abstract][Full Text] [Related]
7. Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.
Bousman CA; Rivard C; Haese JD; Ambrosone C; Hyland A
Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):227-35. PubMed ID: 22223462
[TBL] [Abstract][Full Text] [Related]
8. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
Lee SH; Ahn WY; Seweryn M; Sadee W
BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
[TBL] [Abstract][Full Text] [Related]
9. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
Tomaz PR; Santos JR; Issa JS; Abe TO; Gaya PV; Krieger JE; Pereira AC; Santos PC
Eur J Clin Pharmacol; 2015 Sep; 71(9):1067-73. PubMed ID: 26153084
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada.
Conlon MS; Bewick MA
Nicotine Tob Res; 2011 Nov; 13(11):1076-83. PubMed ID: 21810735
[TBL] [Abstract][Full Text] [Related]
11. Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence.
Etter JF; Hoda JC; Perroud N; Munafò M; Buresi C; Duret C; Neidhart E; Malafosse A; Bertrand D
Addict Behav; 2009 Sep; 34(9):772-5. PubMed ID: 19482438
[TBL] [Abstract][Full Text] [Related]
12. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes.
Saccone NL; Saccone SF; Hinrichs AL; Stitzel JA; Duan W; Pergadia ML; Agrawal A; Breslau N; Grucza RA; Hatsukami D; Johnson EO; Madden PA; Swan GE; Wang JC; Goate AM; Rice JP; Bierut LJ
Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):453-66. PubMed ID: 19259974
[TBL] [Abstract][Full Text] [Related]
13. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
[TBL] [Abstract][Full Text] [Related]
14. The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.
Saccone NL; Wang JC; Breslau N; Johnson EO; Hatsukami D; Saccone SF; Grucza RA; Sun L; Duan W; Budde J; Culverhouse RC; Fox L; Hinrichs AL; Steinbach JH; Wu M; Rice JP; Goate AM; Bierut LJ
Cancer Res; 2009 Sep; 69(17):6848-56. PubMed ID: 19706762
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
Wen L; Jiang K; Yuan W; Cui W; Li MD
Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
[TBL] [Abstract][Full Text] [Related]
16. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
Winterer G; Mittelstrass K; Giegling I; Lamina C; Fehr C; Brenner H; Breitling LP; Nitz B; Raum E; Müller H; Gallinat J; Gal A; Heim K; Prokisch H; Meitinger T; Hartmann AM; Möller HJ; Gieger C; Wichmann HE; Illig T; Dahmen N; Rujescu D
Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1448-58. PubMed ID: 20886544
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.
Chen LS; Baker TB; Jorenby D; Piper M; Saccone N; Johnson E; Breslau N; Hatsukami D; Carney RM; Bierut LJ
Drug Alcohol Depend; 2015 Sep; 154():278-82. PubMed ID: 26142345
[TBL] [Abstract][Full Text] [Related]
18. Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence.
Chen X; Chen J; Williamson VS; An SS; Hettema JM; Aggen SH; Neale MC; Kendler KS
Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):926-33. PubMed ID: 19132693
[TBL] [Abstract][Full Text] [Related]
19. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
Panagiotou OA; Schuit E; Munafò MR; Bennett DA; Bergen AW; David SP
Nicotine Tob Res; 2019 Aug; 21(9):1289-1293. PubMed ID: 30690475
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.
Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
Drug Alcohol Depend; 2022 Oct; 239():109596. PubMed ID: 35981468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
